T0	Limitation 28201 28206	Lyden
T1	Limitation 28420 28423	The
T2	Limitation 29253 29256	The
T3	Limitation 29710 29713	The
T4	Limitation 29879 29887	However,
T5	Limitation 31316 31321	Lyden
T6	Limitation 32129 32132	Our
T7	RecruitmentLessThanExpected 28262 28330	IST-3 recruited only half the number of patients originally intended
T8	UnderpoweredStudy 28342 28418	underpowered for the primary outcome (and more so for the subgroup analyses)
T9	RecruitmentLessThanExpected 28490 28598	trial delayed the approval of the trial in many centres and precluded the participation of several countries
T10	Blinding 29257 29275	absence of masking
T11	Blinding 29772 29835	postal questionnaire or masked telephone interview was unmasked
T13	UnderpoweredStudy 32143 32201	underpowered to reliably detect important subgroup effects
T14	ReliabilityOfMeasurement 29888 29975	self-reported outcome by patients is necessarily subjective and affected by many things
T12	OutcomeMeasures 31345 31435	sampling approach to monitoring in IST-3 was less intense than in many commercial studies,
